Long-term impact of smoking on lung epithelial proliferation in current and former smokers

Journal of the National Cancer Institute

Volumn 93, Issue 14, 2001, Pages 1081-1088

  Lee, J Jack ^a   Liu, Diane ^a   Lee, Jin Soo ^a   Kurie, Jonathan M ^a   Khuri, Fadlo R ^a   Ibarguen, Heladio ^a   Morice, Rodolfo C ^a   Walsh, Garrett ^a   Ro, Jae Y ^a   Broxson, Anita ^a   Hong, Waun Ki ^a   Hittelman, Walter N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; BUFFER; CARCINOGEN; CYCLINE; DNA; EOSIN; FENRETINIDE; HEMATOXYLIN; IMMUNOGLOBULIN G; ISOTRETINOIN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PARAFFIN; PEROXIDASE; PHOSPHATE; PLACEBO; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BRONCHUS BIOPSY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RISK; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; LABELING INDEX; LONG TERM EXPOSURE; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METAPLASIA; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SMOKING CESSATION; SMOKING HABIT; STAINING; STATISTICAL ANALYSIS; TISSUE SECTION; TOBACCO;

EID: 0035908486     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.14.1081     Document Type: Article

References (42)

1. Cancer statistics, 2001
2. Second lung cancers in patients successfully treated for lung cancer
3. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer
4. Smoking, smoking cessation, and lung cancer in the UK since 1950: Combination of national statistics with two case-control studies
5. Epidemiology of lung cancer
6. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: A molecular epidemiologic study
7. Gene-environment interactions in human lung cancer
8. Lung cancer and smoking cessation: Patterns of risk
9. Lung carcinoma in former smokers
10. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
11. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
12. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer
13. Preclinical drug development paradigms for chemopreventives
14. Cancer chemoprevention: Progress and promise
15. Cancer chemoprevention: Progress and promise
16. Field cancerization in oral stratified squamous epithelium: Clinical implications of multicentric origin
17. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer
18. Genetic instability assessments in the lung cancerization field
19. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia
20. Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers
21. The complexities of proliferating cell nuclear antigen
22. The assessment of cellular proliferation by immunohistochemistry: A review of currently available methods and their applications
23. The Ki-67 protein: From the known and the unknown
24. Prognostic significance of p27KIP1 protein and Ki-67 growth fraction in non-small cell lung cancers
25. Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: Prognostic significance and comparison with p53 and bc1-2
26. Increased number of proliferating cells in oral epithelium from smokers and ex-smokers
27. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco
28. N-(4-Hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium
29. Molecular epidemiology: Insights into cancer susceptibility, risk assessment, and prevention
30. Molecular epidemiology and carcinogenesis: Endogenous and exogenous carcinogenesis
31. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer
32. The role of DNA repair capacity in susceptibility to lung cancer: A review
33. Clonal genetic alterations in the lungs of current and former smokers
34. Molecular damage in the bronchial epithelium of current and former smokers
35. Regression of bronchial epidermoid metaplasia in heavy smokers with etretinate treatment
36. Diagnosis of lung cancer: Pathology of invasive and preinvasive neoplasia
37. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: A potential biomarker
38. Genomic instability and its role in neoplasia
39. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis
40. Persistent genetic instability despite decreased proliferation in human lung tissue following smoking cessation